Project Grant R34AA032289
Award Date 9/25/25
Completion Date 8/31/28
Dollars Obligated $686K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
- This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) program, is for a $735,930 feasibility and acceptability study of a large language model-based conversational agent for brief alcohol intervention among emerging adults (ages 18-29). The award will support the development, validation, and open trial of a conversational agent-delivered brief intervention designed to reduce alcohol use and problems...
- This Project Grant award, funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), is for a study to test the efficacy of a novel social media-based intervention to address high-intensity drinking (HID) among emerging adults. The study aims to evaluate an 8-week motivational interviewing-based intervention delivered via private social media messaging with health coaches. The $701,963 award, effective September 15, 2025 through...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), awarded a $309,452 Project Grant to Real Recovery VR, Inc. on Sep 15, 2025. The award supports the development of a virtual reality (VR) platform that counselors can use to enhance treatment techniques and improve outcomes among those with alcohol use disorder (AUD). The project aims to leverage VR technology to provide patients with opportunities to practice coping skills in...
- This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), provides $197,302 to Brown University to develop a virtual reality-based intervention to help adults with alcohol use disorder learn and practice coping skills in realistic high-risk situations. The goal is to improve the efficacy of treatment for alcohol use disorders, which affect over 100 million people worldwide and are a leading cause of...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA), through its Alcohol Research Programs (CFDA 93.273), awarded a $734,468 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for the project "SOCIAL IDENTITY MAPPING FOR ADOLESCENT RECOVERY: DEVELOPING A NOVEL SOCIAL NETWORK INTERVENTION". The goal of this 3-year project, with a period of performance from Sep 2025 to Aug 2028, is to finalize and pilot test a new...
- This federal Project Grant award of $194,062, provided by the National Institute on Alcohol Abuse and Alcoholism (CFDA 93.273 - Alcohol Research Programs), supports the development and pilot testing of a digital pill system (DPS) to measure and improve adherence to acamprosate medication in individuals with alcohol-associated liver disease (ALD) and alcohol use disorder (AUD). The key products/services to be delivered under this 5-year grant include: 1) Developing a user-centered adherence...
- This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (CFDA 93.273 - Alcohol Research Programs) provides $440,566 to Yale University to advance the treatment of alcohol-associated liver disease (ALD). The primary objective is to uncover therapeutic targets and develop effective ALD treatments, with a focus on the methyltransferase-like (METTL) protein family, notably METTL7A, which is highly expressed in ALD patients. The research utilizes cutting-edge technology...
- This federal Project Grant award of $551,464 was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273). The funding will support a 5-year research project led by the Palo Alto Veterans Institute For Research (Pavir) to assess the impact of deep transcranial magnetic stimulation (DTMS) on neural targets associated with alcohol use disorder. The key objectives of the research project are to: 1) evaluate the efficacy of active...
- This Project Grant award, totaling $755,539, was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273). The funding will support research conducted by Emory University to evaluate the real-world utilization, effectiveness, and safety of glucagon-like peptide-1 receptor agonists (GLP-1RAs) as a treatment for alcohol use disorder (AUD). The project aims to leverage administrative claims data and linked electronic health records...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $438,375 Project Grant under the Alcohol Research Programs (CFDA 93.273) to Cedars-Sinai Medical Center to establish a human liver-on-a-chip model for studying alcohol-associated liver disease (ALD). The 2-year project, starting September 2023, aims to investigate the roles of liver sinusoidal endothelial cells and acetaldehyde metabolism in regulating ethanol-induced liver damage as well as the contribution of fibrotic...